Filing Details
- Accession Number:
- 0001225208-16-039751
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-29 16:14:46
- Reporting Period:
- 2016-09-27
- Filing Date:
- 2016-09-29
- Accepted Time:
- 2016-09-29 16:14:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204666 | M Timothy Ring | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-27 | 49,846 | $84.58 | 145,876 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-09-27 | 5,154 | $86.15 | 151,030 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-27 | 26,286 | $228.49 | 124,744 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-09-27 | 28,714 | $227.80 | 96,030 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-09-28 | 37,293 | $84.58 | 133,323 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-28 | 500 | $228.58 | 132,823 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-09-28 | 14,471 | $227.86 | 118,352 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-09-28 | 22,322 | $226.97 | 96,030 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2016-09-27 | 5,154 | $0.00 | 5,154 | $86.15 |
| Common Stock | Option (Right to Buy) | Disposition | 2016-09-27 | 49,846 | $0.00 | 49,846 | $84.58 |
| Common Stock | Option (Right to Buy) | Disposition | 2016-09-28 | 37,293 | $0.00 | 37,293 | $84.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-12-08 | No | 4 | M | Direct | |
| 37,293 | 2021-12-14 | No | 4 | M | Direct | |
| 0 | 2021-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,781 | Indirect | 401(k) Plan |
| Common Stock | 802 | Indirect | By Children |
Footnotes
- Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $228.2200 to $228.9105. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $227.22 to $228.21. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $228.43 to $228.76. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $227.42 to $228.39. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $226.40 to $227.35. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- The reporting person disclaims beneficial ownership of the shares held by his children and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.
- Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Options fully vested in accordance with schedule upon achievement of certain performance criteria.
- Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Options fully vested and are currently exercisable.
Billionaire Hedge Funds
